期刊文献+

马来酸曲美布汀与枯草杆菌二联活菌肠溶胶囊联合对肠易激综合症的疗效及对白细胞介素-6的影响 被引量:15

Investigation of trimebutine maleate tablets and live combined bacillus subtilis and enterococcus faecium enteric-coated capsules for patients with irritable bowel syndrome and change of interleukin-6
暂未订购
导出
摘要 目的观察马来酸曲美布汀与枯草杆菌二联活菌肠溶胶囊联合对肠易激综合症的疗效及对血清白细胞介素-6(IL-6)的影响。方法收集162例肠易激综合症的患者,依入院顺序,分为观察组与对照组(均81例),对照组口服枯草杆菌二联活菌肠溶胶囊(500 mg,每日3次);观察组口服马来酸曲美布汀(0.1 g)联合枯草杆菌二联活菌肠溶胶囊(500 mg),每日3次,疗程均8周,比较2组疗效及对IL-6的影响。结果治疗后,观察组总有效率明显高于对照组患者;2组IL-6均下降,但是观察组的下降值更明显。结论马来酸曲美布汀联合枯草杆菌二联活菌肠溶胶囊治疗肠易激综合症的效果明显,并能有效调节IL-6的含量。 Objective To observe the curative effect of trimebutine maleate tablets and live combined bacillus subtilis and enterococcus faecium enteric-coated capsules for patients with irritable bowel syndrome and change of interleukin-6(IL-6).Methods One hundred and sixty-two patients with irrtable bowel syndrome were divided into two groups.The control group(81 cases) were treated by live combined bacillus subtilis and enterococcus faecium enteric-coated capsules treatment(500 mg,three times daily)for 8 weeks,the trial group(81 cases) were treated by trimebutine maleate tablets(0.1 g,three times daily)and live combined bacillus subtilis and enterococcus faecium enteric-coated capsules(500 mg,three times daily)for 8 weeks.The efficacy and the change of IL-6 in two groups were observed.Results The total effective rate in the trial group was obviously higher than in the control group.The change of IL-6 in the trial group were obviously higher after treatment.Conclusion The treatment of trimebutine maleate tablets and live combined bacillus subtilis and enterococcus faecium enteric-coated capsules can improve the curative effect,regulate the expression of IL-6 in patients with irritable bowel syndroe.
作者 廖如奕 牛灵
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2011年第10期743-745,共3页 The Chinese Journal of Clinical Pharmacology
关键词 马来酸曲美布汀 肠易激综合症 白细胞介素-6 trimebutine maleate tablets irritable bowel syndrome interleukin-6
  • 相关文献

参考文献9

二级参考文献55

共引文献93

同被引文献136

  • 1施烜,魏娟,刘美云,金小红,周焕平,朱万莉,冯迪,杨浩,吕欣.血必净注射液治疗新型冠状病毒肺炎的整体调控作用研究[J].上海中医药杂志,2020(4):46-52. 被引量:34
  • 2丁志鹏,路玉宇.分析应用血必净注射液辅助治疗重症肺炎临床效果及其对患者血气指标的影响[J].名医,2020(11):368-369. 被引量:3
  • 3陆星华,张泰昌.反流性食管炎诊断及治疗指南(2003年)[J].中华消化内镜杂志,2004,21(4):221-222. 被引量:873
  • 4Chiba T,Sato K,Toya Y,et al.Serial changes in cytokine expression in irritable bowel syndrome patients following treatment with calcium polycarbophil[J].Hepato-gastroenterology,2010,58(110-111):1527-1530.
  • 5Drossman DA.The functional gastrointestinal disorders and the Rome III process[J].Gastroenterology,2006,130(5):1377-1390.
  • 6Lee H,Lee S,Choi JE,et al.G protein β3 subunit,interleukin-10,and tumor necrosis factor-α gene polymorphisms in Koreans with irritable bowel syndrome[J].Neurogastroenterology & Motility,2010,22(7):758-763.
  • 7Macarron CP, Palomino AP, Matute de Cardenas JA, et al. De- scendingnecrotizingmediastinitis in a child with chicken-pox. J Thorac Cardiovasc Surg, 2012, 133 ( 1 ) : 271-272.
  • 8徐明鑫,桂艺芳,王冬梅.健脾益肠汤治疗老年人肠道菌群失调临床研究[J].中国药物经济学,2013,8(4):260-261.
  • 9SHEN HL,LI ZY,YE YF.Joint trimebutine probiotic preparations of intestinal flora in patients with irritable bowel syndrome and curative effect observation. The Influence of the Critically Ill Medical Journal (electronic) . 2013
  • 10Weeks now.Sun maleic acid trimebutine Mr Kang perindopril treatment of diarrhea type irritable bowel syndrome,75 cases of clinical observation. Chinese Modern Drug Applications . 2013

引证文献15

二级引证文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部